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To the Editor: We welcome discussion on this important topic and thank Dr 
Cihan for her comments and useful further review of the literature on 
hippocampal damage. Moreover, we absolutely agree that radiation therapy 
is not the only cause of reduction in hippocampal volume. The purpose of our
study (1, 2) was to determine whether radiation therapy in brain tumor 
patients was associated with hippocampal atrophy and whether there was, 
additionally, a dose-dependent effect. Indeed, we did find radiation dose–
dependent atrophy in brain tumor patients. We also demonstrated the power
of quantitative magnetic resonance imaging to measure longitudinal 
hippocampal atrophy in these cancer patients.
As Dr Cihan accurately points out, numerous neurologic conditions have 
been associated with hippocampal volume loss, several of which are 
mentioned in our article. Age is one such factor. In our study, radiation dose 
and age were each significantly associated with atrophy in a multivariable 
model. It is quite possible that increased statistical power would reveal 
significant effects for seizures and systemic therapy as well, consistent with 
findings in patients not undergoing radiation therapy (3, 4). We acknowledge
this limitation to the study in our manuscript. Dr Cihan lists additional factors
that could potentially affect hippocampal volume, such as prolonged 
corticosteroid administration and, critically, chemotherapy.
We join Dr Cihan in calling for careful study of several plausible risk factors 
for hippocampal atrophy. These factors should be additionally studied in 
multivariable analyses powered to detect interactions. A case report of 
marked unilateral hippocampal atrophy in a patient with glioblastoma 
illustrates dramatic hippocampal damage in the context of numerous 
potential causes, including surgery, radiation therapy, chemotherapy, 
corticosteroids, antiepileptic medications, and repeated generalized, tonic-
clonic seizures (5). Other studies found that hippocampal volumes can be 
small in patients with brain tumors even before radiation therapy (6) or after 
bevacizumab even outside the high-dose radiation therapy field (7). 
Hippocampal volumes were also smaller than expected in survivors of breast
cancer who received chemotherapy (4).
Preserving the cognitive abilities of brain tumor survivors will best be 
accomplished if we understand the effects of each of these possible 
contributors and how those effects might be mitigated. For radiation, it 
seems that dose reduction to the hippocampus is a reasonable strategy for 
investigation. As demonstrated in our present work, quantitative magnetic 
resonance imaging may prove to be a powerful tool to improve 
understanding of cancer treatments on hippocampal volume.
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